Female preponderance of Parkinson's disease in Japan

被引：55

作者：

Kimura, H

Kurimura, M

Wada, M

Kawanami, T

Kurita, K

Suzuki, Y

Katagiri, T

Daimon, M

Kayama, T

Kato, T

机构：

[1] Yamagata Univ, Sch Med, Dept Internal Med 3, Yamagata 9909585, Japan

[2] Yamagata Univ, Sch Med, Dept Neurosurg, Yamagata 9909585, Japan

[3] Yamagata Prefectural Nihonkai Hosp, Dept Neurol, Yamagata, Japan

[4] Yamagata Prefectural Kahoku Hosp, Dept Internal Med, Yamagata, Japan

[5] Yamagata Prefectural Kahoku Hosp, Dept Neurol, Yamagata, Japan

来源：

NEUROEPIDEMIOLOGY | 2002年 / 21卷 / 06期

关键词：

estrogen; gender; prevalence; sex; Yamagata; Japan; Parkinson's disease;

D O I：

10.1159/000065527

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A male preponderance of Parkinson's disease (PD) has been reported in European countries and the USA. To verify this issue in Japanese patients with PD, we examined the age- and gender-specific prevalence of PD in Yamagata Prefecture (population 1,244,040), Japan. The prevalence of PD was 61.3/100,000 men and 91.0/100,000 women, showing that women were significantly more affected by PD than men (p < 0.001). Contrary to the findings in Europe and the USA, the results indicate a female preponderance of PD among the Japanese population. Copyright (C) 2002 S. Karger AG, Basel.

引用

页码：292 / 296

页数：5

共 24 条

[1] Parkinson's disease and parkinsonism in a longitudinal study - Two-fold higher incidence in men
Baldereschi, M
Di Carlo, A
Rocca, WA
Vanni, P
Maggi, S
Perissinotto, E
Grigoletto, F
Amaducci, L
Inzitari, D
[J]. NEUROLOGY, 2000, 55 (09) : 1358 - 1363
[2] Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients -: A crossover study
Blanchet, PJ
Fang, J
Hyland, K
Arnold, LA
Mouradian, MM
Chase, TN
[J]. NEUROLOGY, 1999, 53 (01) : 91 - 95
[3] Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990
Bower, JH
Maraganore, DM
McDonnell, SK
Rocca, WA
[J]. NEUROLOGY, 1999, 52 (06) : 1214 - 1220
[4] Bower JH, 2000, MOVEMENT DISORD, V15, P819, DOI 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO
[5] 2-P
[6] Neuroprotective effects of estrogens: potential mechanisms of action
Green, PS
Simpkins, JW
[J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (4-5) : 347 - 358
[7] Menstrual-related changes in motoric function in women with Parkinson's disease
Kompoliti, K
Comella, CL
Jaglin, JA
Leurgans, S
Raman, R
Goetz, CG
[J]. NEUROLOGY, 2000, 55 (10) : 1572 - 1574
[8] Changing epidemiology of Parkinson's disease in southwestern Finland
Kuopio, AM
Marttila, RJ
Helenius, H
Rinne, UK
[J]. NEUROLOGY, 1999, 52 (02) : 302 - 308
[9] Epidemiology of Parkinson's disease in Yonago City, Japan: Comparison with a study carried out 12 years ago
Kusumi, M
Nakashima, K
Harada, H
Nakayama, H
Takahashi, K
[J]. NEUROEPIDEMIOLOGY, 1996, 15 (04) : 201 - 207
[10] Postmenopausal estrogen use and Parkinson's disease with and without dementia
Marder, K
Tang, MX
Alfaro, B
Mejia, H
Cote, L
Jacobs, D
Stern, Y
Sano, M
Mayeux, R
[J]. NEUROLOGY, 1998, 50 (04) : 1141 - 1143

← 1 2 3 →